Eli Lilly slips, Novo Nordisk holds firm as generic weight-loss drugs flood India
Eli Lilly loses share in India’s GLP‑1 market as cheap semaglutide generics surge, while Novo holds steady after deep price cuts to defend Ozempic, Wegovy.
The News Flicker
Eli Lilly loses share in India’s GLP‑1 market as cheap semaglutide generics surge, while Novo holds steady after deep price cuts to defend Ozempic, Wegovy.
The Eli Lilly and Novo Nordisk logos. The market share of India's most popular weightloss drugmaker, Eli Lilly, slipped in March, while rival Novo Nordisk held steady even as Indian generic drugmake…
Originally published by CNBC. Read the full article →
More from India
Sebi backs removal of LTCG tax for foreign investors: Report
To boost foreign investment interest, India's Securities and Exchange Board has put forth a proposal to scrap long-term capital gains tax for foreign investors and extend tax relief to mutual fund investors. This move is designed to counteract the high capita…
The News Flicker·November 2, 2026
India, EU discuss FTA implementation issues ahead of signing in December
India and the European Union have discussed implementation issues of the free trade agreement (FTA), which is scheduled for signing in December, an official statement said on Monday. The issues were discussed during the visit of Commerce Secretary Rajesh Agar…
The News Flicker·November 2, 2026
India news: Gandhi vows to step up pressure on Modi at protest rally
Rahul Gandhi said the removal of election chief Gyanesh Kumar will be the first step to getting the country on the right track. Follow DW for more. Thousands attended the Rahul Gandhi-led INDIA bloc's rally against top poll official Gyanesh Kumar Authorities …
The News Flicker·November 2, 2026